270 related articles for article (PubMed ID: 26152085)
21. Malignant melanoma-The cradle of anti-neoplastic immunotherapy.
Koller KM; Wang W; Schell TD; Cozza EM; Kokolus KM; Neves RI; Mackley HB; Pameijer C; Leung A; Anderson B; Mallon CA; Robertson G; Drabick JJ
Crit Rev Oncol Hematol; 2016 Oct; 106():25-54. PubMed ID: 27637351
[TBL] [Abstract][Full Text] [Related]
22. Novel immunotherapies as potential therapeutic partners for traditional or targeted agents: cytotoxic T-lymphocyte antigen-4 blockade in advanced melanoma.
Agarwala SS
Melanoma Res; 2010 Feb; 20(1):1-10. PubMed ID: 19952852
[TBL] [Abstract][Full Text] [Related]
23. Normalization Cancer Immunotherapy for Melanoma.
Vesely MD; Chen L
J Invest Dermatol; 2020 Jun; 140(6):1134-1142. PubMed ID: 32092349
[TBL] [Abstract][Full Text] [Related]
24. Immunotherapy of advanced or metastatic melanoma.
Cebon J; Gedye C; John T; Davis ID
Clin Adv Hematol Oncol; 2007 Dec; 5(12):994-1006. PubMed ID: 18277962
[TBL] [Abstract][Full Text] [Related]
25. Advances in specific immunotherapy of malignant melanoma.
Curiel-Lewandrowski C; Demierre MF
J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):167-85; quiz 186-8. PubMed ID: 10906637
[TBL] [Abstract][Full Text] [Related]
26. Medical management of melanoma.
Brown CK; Kirkwood JM
Surg Clin North Am; 2003 Apr; 83(2):283-322, viii. PubMed ID: 12744611
[TBL] [Abstract][Full Text] [Related]
27. Metastatic Melanoma: Insights Into the Evolution of the Treatments and Future Challenges.
Millet A; Martin AR; Ronco C; Rocchi S; Benhida R
Med Res Rev; 2017 Jan; 37(1):98-148. PubMed ID: 27569556
[TBL] [Abstract][Full Text] [Related]
28. A multidisciplinary approach to toxicity management of modern immune checkpoint inhibitors in cancer therapy.
Kottschade L; Brys A; Peikert T; Ryder M; Raffals L; Brewer J; Mosca P; Markovic S;
Melanoma Res; 2016 Oct; 26(5):469-80. PubMed ID: 27306502
[TBL] [Abstract][Full Text] [Related]
29. Immunotherapy of malignant melanoma.
Kadison AS; Morton DL
Surg Clin North Am; 2003 Apr; 83(2):343-70. PubMed ID: 12744613
[TBL] [Abstract][Full Text] [Related]
30. [New treatments for metastatic melanoma: a first hope].
Robert C; Mateus C
Rev Prat; 2011 Nov; 61(9 Suppl):S1-2. PubMed ID: 22338196
[No Abstract] [Full Text] [Related]
31. T cell receptor therapy against melanoma-Immunotherapy for the future?
Winge-Main AK; Wälchli S; Inderberg EM
Scand J Immunol; 2020 Oct; 92(4):e12927. PubMed ID: 32640053
[TBL] [Abstract][Full Text] [Related]
32. Immunotherapy for Melanoma.
Albittar AA; Alhalabi O; Glitza Oliva IC
Adv Exp Med Biol; 2020; 1244():51-68. PubMed ID: 32301010
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of immunotherapy in the treatment of melanoma.
Faries MB
Surg Oncol Clin N Am; 2006 Apr; 15(2):399-418. PubMed ID: 16632223
[TBL] [Abstract][Full Text] [Related]
34. Immunotherapy of melanoma.
Parmiani G; Castelli C; Rivoltini L; Casati C; Tully GA; Novellino L; Patuzzo A; Tosi D; Anichini A; Santinami M
Semin Cancer Biol; 2003 Dec; 13(6):391-400. PubMed ID: 15001157
[TBL] [Abstract][Full Text] [Related]
35. The treatment of melanoma with an emphasis on immunotherapeutic strategies.
Jack A; Boyes C; Aydin N; Alam K; Wallack M
Surg Oncol; 2006 Jul; 15(1):13-24. PubMed ID: 16815006
[TBL] [Abstract][Full Text] [Related]
36. Emerging therapies for melanoma.
Katipamula R; Markovic SN
Expert Rev Anticancer Ther; 2008 Apr; 8(4):553-60. PubMed ID: 18402522
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study.
Gullo G; Rubatto M; Fava P; Brizio M; Tonella L; Ribero S; Medri M; Avallone G; Mastorino L; Fierro MT; Stanganelli I; Quaglino P
Dermatol Ther; 2022 Jun; 35(6):e15492. PubMed ID: 35384181
[TBL] [Abstract][Full Text] [Related]
38. [A malignus melanoma immunterápiájának lehetoségei].
Ladányi A
Magy Onkol; 2003; 47(1):113-7. PubMed ID: 12704464
[TBL] [Abstract][Full Text] [Related]
39. Novel Targets in Melanoma: Intralesional and Combination Therapy to Manipulate the Immune Response.
Gingrich AA; Kirane AR
Surg Oncol Clin N Am; 2020 Jul; 29(3):467-483. PubMed ID: 32482321
[TBL] [Abstract][Full Text] [Related]
40. Immune checkpoint inhibitors in melanoma provide the cornerstones for curative therapies.
Eggermont AM; Maio M; Robert C
Semin Oncol; 2015 Jun; 42(3):429-35. PubMed ID: 25965361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]